• 1

Numbers and Facts

  • Founding of RHEACELL in 2012
  • Subsidiary of TICEBA GmbH
  • Start of business activities in July 2012
  • Offices and laboratory at technology park Heidelberg
  • 9 employees

Mission and Vision

RHEACELL is dedicated to the development of human pharmaceuticals based on ABCB5+ mesenchymal stem cells. For selected indications RHEACELL strives to improve the quality of life as well as to alleviate and heal ailments of patients.


RHEACELL is obligated to meet the requirements of the European law throughout the whole development process of stem cell-based pharmaceuticals. Also, latest international findings of science and research as well as in-house know-how of RHEACELL's qualified staff play a key role in realizing the mission. Throughout the entire development process, the requirements of Good Manufacturing Practice, Good Laboratory Practice und Good Clinical Practice are met.


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.